Re: Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

Faculty Opinions recommendation of Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1157429.617587 ◽

2009 ◽

Author(s):

George Huang

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

Yearbook of Urology ◽

10.1016/s0084-4071(09)79264-4 ◽

2009 ◽

Vol 2009 ◽

pp. 126-127

Author(s):

A.S. Kibel

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

The Journal of Urology ◽

10.1016/j.juro.2008.11.032 ◽

2009 ◽

Vol 181 (3) ◽

pp. 956-962 ◽

Cited By ~ 820

Author(s):

Ian M. Thompson ◽

Catherine M. Tangen ◽

Jorge Paradelo ◽

M. Scott Lucia ◽

Gary Miller ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

Yearbook of Medicine ◽

10.1016/s0084-3873(10)79868-0 ◽

2010 ◽

Vol 2010 ◽

pp. 151-152

Author(s):

C.A. Lawton

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

Yearbook of Oncology ◽

10.1016/s1040-1741(09)79425-4 ◽

2010 ◽

Vol 2010 ◽

pp. 78-79

Author(s):

C.A. Lawton

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Commentary on Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term follow-up of a randomized clinical trial

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2009.04.016 ◽

2009 ◽

Vol 27 (4) ◽

pp. 456-457 ◽

Cited By ~ 1

Author(s):

Mark A. Ritter

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Adjuvant Radiotherapy ◽

Long Term Follow Up

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

Yearbook of Urology ◽

10.1016/s0084-4071(09)79295-4 ◽

2009 ◽

Vol 2009 ◽

pp. 124-125

Author(s):

G.L. Andriole

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Re: Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastasis and Improves Survival: Long-term Follow-up of a Randomized Clinical Trial

European Urology ◽

10.1016/j.eururo.2009.05.039 ◽

2009 ◽

Vol 56 (2) ◽

pp. 398-399

Author(s):

Eduardo Solsona

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Adjuvant Radiotherapy ◽

Long Term Follow Up

Faculty Opinions recommendation of Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.723494560.793514264 ◽

2016 ◽

Author(s):

Badrinath Konety

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Adjuvant Radiotherapy ◽

Advanced Prostate Cancer

Long-term Distress After Radical Prostatectomy Versus Watchful Waiting in Prostate Cancer: A Longitudinal Study from the Scandinavian Prostate Cancer Group-4 Randomized Clinical Trial

European Urology ◽

10.1016/j.eururo.2013.02.025 ◽

2013 ◽

Vol 64 (6) ◽

pp. 920-928 ◽

Cited By ~ 53

Author(s):

Anna Bill-Axelson ◽

Hans Garmo ◽

Lars Holmberg ◽

Jan-Erik Johansson ◽

Hans-Olov Adami ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Longitudinal Study ◽

Radical Prostatectomy ◽

Watchful Waiting ◽

Cancer Group ◽

Group 4